featured Trending

A village-born financier, a global Lions gift and the long argument that prosperity must enrich the soil beneath it.

Valapad, Thrissur — In July 2026, Lion V. P. Nandakumar, Chairman and Managing Director of Manappuram Finance Ltd, was recognised on a global stage for a contribution of US$1.5 million to the Lions Clubs International Foundation (LCIF), the charitable arm of Lions International and one of the world’s largest humanitarian service organisations. The recognition came at the Lions International Convention in Hong Kong, where he and his wife, Lion Sushma Nandakumar, were honoured for exceptional humanitarian service. The gift will underwrite LCIF programmes in education, healthcare, disaster relief, youth empowerment, vision care and community development.

Speaking in Hong Kong, Lion Nandakumar said: “Giving back to society has always been at the heart of everything we do. Through this contribution to the Lions Clubs International Foundation, we hope to strengthen humanitarian initiatives that create sustainable and meaningful change in people’s lives across communities. Together, we can build a more compassionate and inclusive future.” The Donation is not a one-off gesture. It is the latest and most international expression of an association with the Lions movement that stretches back more than four decades.

Lion Nandakumar’s ties to Lions Clubs International began in 1981, when he joined the Triprayar Lions Club. He later served as Multiple District Council Chairperson, as a board appointee and as a member of the LCIF Corporate, Foundation and Government Gifts Committee. In July 2019, at the association’s 102nd International Convention in Milan, he was elected International Director. He is now a Past International Director and has received the International President’s Leadership Award, the International President’s Award and the Ambassador of Good Will Award — the highest honour the association confers on its members.

That long association has a practical counterpart at home. In partnership with Lions clubs across Kerala, the Manappuram Foundation runs a housing programme for the homeless and the severely disabled; by late 2025 the collaboration had completed more than 550 houses, with further dwellings under construction. The handover of the 550th home went to a differently-abled beneficiary in Edathiruthy village in Thrissur district. The Lions connection, in this record, is not a ceremonial affiliation. It is the network through which a village trust learned to build at scale — houses, hospital units, flood relief, school kits — without abandoning the local flavour of the original gospel. The US$1.5 million gift to LCIF is the same partnership written in a larger hand.

The Roots Beneath The Reach

That donation is not an exception from Lion Nandakumar’s record. It is the most international expression yet of a philanthropy that still answers to a coastal village called Valapad in Thrissur district, Kerala. Manappuram Finance was founded in 1949 by Lion Nandakumar’s father, Mr V. C. Padmanabhan, in Valapad. From a modest pawnbroking concern it has grown into a non-banking financial company with more than 5000 branches across India. Lion Nandakumar took charge in 1986. He remains Managing Trustee of the Manappuram Foundation, the group’s charitable arm, and has long set aside a substantial share of profit for public purpose. Charity, in his telling, is not an ornament on the business. It is part of the firm’s original bond with the community that first sustained it.

Fabrício Oliveira, Chairperson of the Lions Clubs International Foundation (LCIF), honors Million Dollar Donor V.P. Nandakumar and his spouse Sushama Nandakumar at the Lions International Convention held in Hong Kong

When Lion Nandakumar speaks of giving, the language is local before it is global. His “Gospel of Giving” is rooted in the wellbeing of the neighbourhood: the fishing hamlets, panchayats and small towns around Valapad. The corporate headquarters has never left that village. He has declined to shift it, arguing that proximity is obligation rather than nostalgia. The prosperity of people around the company’s birthplace, he maintains, is a first duty. Beyond that circle lies a wider claim: the poor and the infirm, wherever they are found, deserve organised care.

He has put the idea in the form of a parable. “When a tree grows, its roots will also grow deeper and wider to give it a firm footing. Similarly, when an organisation grows, its prosperity should trickle down to the poor in such a way that it helps create goodwill and brand value among the local populace. Essentially, it provides the company a strong grip on the ground.” An institution’s economic progress, in this view, must register in the neighbourhood as wellbeing, dignity and social harmony.

Before The Statute, A Trust

Soon after he took the helm, Lion Nandakumar concluded that goodwill alone was insufficient. Meaningful intervention required a dedicated instrument. The Manappuram Foundation was constituted in October 2009 as a charitable trust — four years before the Companies Act made CSR spending mandatory for large Indian firms. The vision was concise: healthy, educated and happy communities.

A CSR initiative implemented by Manappuram Foundation in association with LCIF was inaugurated by Lion Gudrun Yngvadottir, LCIF Chairperson, in the presence of V.P. Nandakumar

The first major project was not a ceremonial donation. It was an attempt to close a gap that official schemes had left open. Many below-poverty-line families in the coastal belt of Thrissur were either unaware of existing government health insurance, or unable to pay even the nominal premium. In 2010 the Foundation rolled out the Janaraksha Manappuram Free Health Insurance Scheme. It extended cover of up to Rs 60,000 per family to about 20,000 BPL households — roughly one lakh people — across seven panchayats in the Nattika belt, including Valapad. Over seven years the scheme reimbursed nearly Rs 11 crore in treatment costs, with no age restriction and a wide range of medical procedures. The model predated the Union government’s Ayushman Bharat programme of 2018. It also set the Foundation’s subsequent pattern: identify a local failure of access, fund it properly and stay long enough for the benefit to become visible.

Lives Restored, Not Merely Assisted

Each year the Foundation, drawing on the company’s CSR outlay, attempts to convert that design into individual recoveries. Gopan’s case is one such instance. Bedridden for years after spinal injuries, he left his household in deep distress. With the Foundation’s support he regained his health and now sustains his family through a small business. The episode is typical of the work the Medical Treatment Fund is meant to do: intervene when a medical bill would otherwise collapse a household.

Million Dollar Donor V.P. Nandakumar stands alongside other distinguished donors honoured on stage at the Lions International Convention held in Hong Kong

Similar interventions recur across the Foundation’s case files — dialysis support, assistive devices, scholarships, houses for the landless and the disabled, and seed capital for women who can run a trade if they are given a first chance. The method is unglamorous: identify the person, pay what the system will not, and follow through until the beneficiary can stand without the grant.

The Scale Of The Purse

In FY 2024–25 Manappuram Finance spent more than Rs 46 crore on CSR, meeting and slightly exceeding its statutory obligation. The programmes cut across education, skill development, childcare, art and culture, sports, sustainable livelihood, drinking water and sanitation, digital access, and support for women entrepreneurs. The largest concentrations of money and effort remain healthcare, education and mobility.

Healthcare programmes have reached more than 1.24 lakh people through clinical services, diagnostic infrastructure and community outreach. Education spending has gone into school and academy infrastructure and into scholarships for students from economically weaker families. Under community and environmental heads the Foundation has backed solar installations and waste-management projects. The Chikitsa Sahaya Padhathi, or Medical Treatment Fund, has become the flagship of direct aid. In a single recent year it extended financial assistance to more than 300 patients from BPL and economically weaker households. The wider health brief also covers children with cancer and Type-1 diabetes, persons with intellectual disabilities, burn survivors, the physically challenged and members of the transgender community, as well as palliative care, emergency ambulance services, counselling and psychotherapy, and yoga.

Mobility is treated as a right rather than a concession. The “Wings on Wheels” programme supplies customised three-wheeler scooters to differently-abled beneficiaries; 75 such vehicles were donated in FY 2024–25 alone, at a cost of about Rs 81 lakh. Parallel drives under names such as Sahayathraku Snehasparshamayi have distributed electric wheelchairs to persons with muscular dystrophy and other disabilities. The premise is simple: without movement there is no livelihood, and without livelihood charity becomes a recurring bill rather than a restoration of independence.

Grip On The Ground

In May 2025 Lion Nandakumar received the EdelGive Hurun India Award for Exemplary Leadership in Corporate Social Responsibility. Accepting it, he said that making a difference in even one person’s life is a success in itself. The remark sits beside the tree he likes to describe. The canopy is now a listed NBFC with a national branch network that has made a seven-figure gift to one of the world’s principal humanitarian foundations. The roots are still in Valapad: a health card in a coastal household, a scooter that takes a disabled worker to a shop, a house whose key is handed over by a Lions officer and a Foundation trustee, both standing on the same dais.

V.P. Nandakumar pictured alongside Lion A.P. Singh, International President; Lion Sangeeta Jatia, Board Appointee; and Lion Saju Antony Pathadan, Past Multiple Council Chairperson, Lions International

That is the argument his philanthropy makes, and the standard against which it asks to be judged. Growth that does not thicken the soil beneath it is, in this telling, only height. The work of the Manappuram Foundation — and the Hong Kong recognition that now travels with the Lions movement — is an attempt to prove the contrary: that a firm can rise, give across continents and still keep its footing among the people who first gave it ground.

The landmark donation will continue to support and nature global humanitarian assistance for the needy.

Pic courtesy: Pegaus photography/ images are subject to copyright

featured News Trending

Albania is emerging as a growing destination for dental tourism, with its capital Tirana attracting international patients seeking affordable treatments. The city has nearly 400 dental clinics serving a population of around 600,000, while many clinics now market their services in English and Italian to reach overseas customers. Dental implants typically cost about €600 per tooth, significantly below prices in countries such as the UK, France and Germany.

British patient Anthony Hook travelled to Tirana after becoming interested in the city’s numerous dental clinics and eventually underwent several visits for dental implant treatment. He said Albania appealed to him because of its lower costs and his concerns about reports of complications involving some medical procedures in Turkey. The country’s expanding network of low-cost flights has also made it easier for patients from across Europe to combine treatment with a holiday.

Albanian authorities and healthcare providers see medical tourism as a promising new industry but are also concerned about unregulated operators damaging the sector’s reputation. Prime Minister Edi Rama said the government is considering ways to identify reputable medical tourism providers as international arrivals continue to rise. Alongside dental care, Albania is also attracting visitors for hair transplants, with some clinics employing specialists from Turkey or operating as branches of Turkish businesses.

Pic courtesy: google/ images are subject to copyright

featured News Trending

Ireland’s health service operator, the Health Service Executive (HSE), has been fined €645,000 by the country’s Data Protection Commission (DPC) after medical records were found stored in unsuitable and poorly maintained locations. Inspections revealed records kept in areas including a disused bathroom and a turf shed, with some storage sites affected by mould, poor lighting and animal droppings.

The DPC said the records were kept in a state of serious disorganisation and neglect, creating risks of unauthorised access to sensitive medical information. Some documents had been damaged or effectively destroyed by mould, rubble and decay. The regulator found that the problems involved both the physical condition of storage facilities and the protection and integrity of the records.

The HSE has been ordered to audit all its storage facilities, remove records from unsuitable locations and introduce a proper management system for paper records. The organisation, which was previously fined €65,000 in 2020 for similar failures, accepted the findings and said it would follow the recommendations. It also apologised to patients and people using its services.

Pic courtesy: google/ images are subject to copyright

featured

The Unique Times Business Summit 2026, presented by Manappuram Finance Ltd and organized by Pegasus Global Pvt. Ltd., was successfully held on August 9, 2026, at Le Méridien Kochi. Powered by FICF, INMECC, Alcazar Watches, Vibe Munnar and DQUE T-Shirts, the summit brought together distinguished leaders from the healthcare, hospitality, tourism and business sectors to deliberate on the theme, “Transforming Tourism Through Hospitality, Healthcare & Wellness.”

The function was inaugurated by Shri V. P. Nandakumar, Chairman and Managing Director of Manappuram Finance Ltd. The discussion was moderated by M. P. Joseph IAS, former IAS officer and former United Nations civil servant.

The summit featured an eminent panel comprising Shri V. P. Nandakumar, Chairman and Managing Director of Manappuram Finance Ltd.; Dr. S. Sajikumar, Chief Physician and Managing Director of Dhathri Ayurveda Hospital & Panchakarma Centre; Dr. Jose Chacko Periappuram, Founder and Chairman of Heart Care Foundation; Shri James Mathew, CEO and Managing Partner of UHY James; Prof. (Dr.) Suresh H. Advani, Chairman of Smita Memorial Hospital and Research Centre; Shri Manu G, Airport Director of Cochin International Airport Limited (CIAL); and Shri Rajesh Malik, Promoter of Carnoustie Ayurvedic & Wellness Resort.

The panel discussion explored the growing synergy between tourism, hospitality, healthcare and wellness, highlighting Kerala’s potential as a global destination for medical tourism and holistic wellness experiences. The speakers collectively emphasized the importance of innovation, sustainable development and strategic collaborations in enhancing the tourism ecosystem and strengthening the state’s position on the international stage.

The summit, led by Dr. Ajit Ravi, Founder & Chairman of Pegasus Global Pvt. Ltd., served as a significant platform for industry experts and policymakers to exchange ideas on the future of wellness-driven tourism. The event reinforced the need for integrated approaches that combine healthcare excellence, world-class hospitality and sustainable tourism practices to drive economic growth and global recognition.

Pic Courtesy: Pegasus Photography/ images are subject to copyright

featured News Trending

AstraZeneca has reportedly held preliminary talks with Bristol Myers Squibb over a potential merger that could create one of the world’s largest pharmaceutical companies, with a combined market value of nearly $400 billion. According to a Reuters source, it remains unclear whether discussions are ongoing. AstraZeneca declined to comment, while Bristol Myers did not immediately respond.

A merger would face significant regulatory scrutiny, particularly from U.S. antitrust authorities, due to the companies’ overlapping cancer drug portfolios. Both firms generate a substantial share of their revenue from oncology treatments, making competition concerns a key hurdle if negotiations progress.

The proposed deal would mark the first major pharmaceutical merger since 2020. Bristol Myers has been pursuing smaller acquisitions to strengthen its pipeline as key drugs approach patent expiry, while AstraZeneca continues to post strong growth driven by demand for its cancer and rare disease medicines.

Pic courtesy: google/ images are subject to copyright

featured News Trending

France’s National Assembly has approved a landmark assisted dying bill after years of political debate, voting 291 to 241 in favour of the legislation. The bill would allow eligible adults with a serious, incurable, life-threatening illness in an advanced or terminal stage to request assisted dying under strict legal safeguards. The law must still undergo constitutional review before it can take effect.

Under the proposed legislation, patients must voluntarily request the procedure and obtain approval from a doctor following consultations within 15 days. After a mandatory two-day reflection period, the patient would generally administer the life-ending medication themselves. If they are physically unable to do so, a doctor or nurse could assist, provided the patient’s consent is confirmed on the day of the procedure.

The legislation remains politically and socially divisive, drawing opposition from religious groups and some medical professionals, while opinion polls indicate broad public support. Prime Minister Sébastien Lecornu has referred key provisions of the bill to France’s Constitutional Council for review, including the reflection period, consent rules for protected patients, and the role of palliative care facilities before the law can be formally enacted.

Pic courtesy: google/ images are subject to copyright

featured News

Mr. V. P. Nandakumar, Chairman and Managing Director of Manappuram Finance Ltd., has contributed US$1.5 million to Lions Clubs International Foundation (LCIF), the charitable arm of Lions International. The contribution will support the foundation’s humanitarian programmes across the world, including initiatives in education, healthcare, disaster relief, youth empowerment, vision care, and community development. The donation reflects Mr. Nandakumar’s long-standing commitment to philanthropy through the Manappuram Foundation and the Lions movement.

In recognition of their outstanding humanitarian contributions, Mr. Nandakumar and his wife, Mrs. Sushma Nandakumar, were honoured at the Lions International Convention held in Hong Kong. The recognition acknowledges their continued efforts in advancing community welfare and supporting impactful social initiatives through organized humanitarian service.

Speaking on the occasion, Mr. Nandakumar said that giving back to society has always been central to his vision and expressed hope that the contribution would strengthen humanitarian initiatives that bring sustainable change to communities worldwide. Through the Manappuram Foundation, he has consistently supported projects in education, healthcare, disaster relief, women’s empowerment, skill development, and financial inclusion. The latest contribution to LCIF further reinforces his commitment to global humanitarian service and inclusive community development.

Pic Courtesy: google/ images are subject to copyright

featured News Trending

Pharmaceutical giant Eli Lilly has reinforced its dominance in the rapidly growing obesity treatment market after presenting promising trial results for its experimental drug retatrutide. Data shared at the American Diabetes Association conference showed the once-weekly injection could deliver greater weight loss than any obesity drug currently available or under development, boosting investor confidence in the company’s future prospects.

Several competitors, including Roche, AstraZeneca, Pfizer, and Novo Nordisk, also unveiled new obesity treatment data. While their drugs showed comparable weight-loss results to existing therapies, analysts believe Lilly’s next-generation products remain ahead of the competition. Following the conference, Lilly’s shares rose while several rival drugmakers saw declines.

As more obesity treatments enter development, companies are increasingly focusing on different patient needs, balancing weight-loss effectiveness with improved tolerability. Side effects such as nausea and vomiting remain a major challenge for current GLP-1-based therapies, prompting manufacturers to invest in newer options that offer fewer gastrointestinal issues while maintaining strong results.

Pic courtesy: google/ images are subject to copyright

featured News Trending

Lower pricing structures for oral weight-loss medications from Novo Nordisk and Eli Lilly are increasingly motivating patients to transition away from compounded drugs toward authentic branded options. Historically, the rampant shortages of branded injectable obesity treatments allowed compounding pharmacies to flourish by mixing their own personalized formulations. However, the U.S. launch of Novo’s oral Wegovy pill in January and Lilly’s Foundayo pill in April has shifted the market dynamic. Because the lowest doses of these newly introduced pills are priced at approximately $149 per month—making them significantly cheaper than their injectable counterparts and on par with compounded variants—patients are actively requesting to switch to the heavily regulated, FDA-approved pharmaceutical options.

Despite the financial appeal of the oral alternatives, the two medications possess distinct medical profiles that influence patient and provider preferences. Novo’s oral Wegovy currently benefits from robust brand familiarity and established clinical data proving its heart-protective benefits, leading to a projected weight reduction of roughly 14% over 64 weeks. Conversely, Lilly’s Foundayo lacks long-term cardiovascular data and yields a slightly lower average weight loss of 11% over 72 weeks, yet it offers a distinct logistical advantage by eliminating the strict fasting requirements necessary for Wegovy. While individual patient hesitation regarding the newer Foundayo remains a factor, market analysts predict that its overall convenience will ultimately help Eli Lilly close the market-share gap with Novo Nordisk.

A broader adoption of these branded weight-loss pills continues to face substantial insurance hurdles, as doctors report a persistent cycle of coverage denials from commercial insurers who hesitate to finance preventive obesity care. Eli Lilly is actively countering these obstacles by expanding coverage through major pharmacy benefit managers, while Novo Nordisk is utilizing retail partnerships to broaden patient access. Medical professionals are highly optimistic about an upcoming U.S. government initiative slated to cover GLP-1 medications for Medicare patients from July 2026 through 2027, anticipating it will act as a catalyst for wider commercial insurance coverage. Ultimately, healthcare providers emphasize that these affordable oral options are successfully expanding the anti-obesity market to reach new patient demographics who previously declined treatment solely due to high costs.

Pic courtesy: google/ images are subject to copyright

featured News Trending

Vatican has stated that Catholics may receive organ transplants from animals, endorsing the practice as medical science advances. The guidance supports the use of animal tissues, provided procedures follow ethical standards and avoid cruelty.

The decision addresses xenotransplantation, a process involving the transfer of organs or tissues between species. Pope Leo XIV’s administration reaffirmed that there are no religious objections to such treatments, as long as they are conducted responsibly and transparently.

The Vatican also urged doctors to clearly communicate risks, including possible organ rejection and infections. While still rare, animal-to-human transplants are gaining traction, marking a significant step forward in medical innovation.

Pic courtesy: google/ images are subject to copyright